NCT03444831View on ClinicalTrials.gov

Buspirone Plus Omeprazole for Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

March 1, 2017

Study Completion Date

April 1, 2017

Conditions
Dyspepsia
Interventions
DRUG

Buspirone

Buspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.

DRUG

Placebo Oral Tablet

Buspirone placebo QID after meal plus 20mg omeprazole before breakfast.

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT03444831 - Buspirone Plus Omeprazole for Functional Dyspepsia | Biotech Hunter | Biotech Hunter